Repurposing bioactive aporphine alkaloids as efflux pump inhibitors

FG Avci, B Atas, CS Aksoy, E Kurpejovic, GG Toplan… - Fitoterapia, 2019 - Elsevier
Extrusion of drugs or drug-like compounds through bacterial efflux pumps is a serious health
issue that leads to loss in drug efficacy. Combinatorial therapies of low-efficacy drugs with …
被引用次数：13 相关文章
[PDF] hal.science

[PDF][PDF] Repurposing bioactive aporphine alkaloids as efflux pump inhibitors

FG Avci, B Atas, CS Aksoy, E Kurpejovic, GG Toplan… - Fitoterapia, 2019 - hal.science
Extrusion of drugs or drug-like compounds through bacterial efflux pumps is a serious health
issue that leads to loss in drug efficacy. Combinatorial therapies of low-efficacy drugs with …

Repurposing bioactive aporphine alkaloids as efflux pump inhibitors

FG Avci, B Atas, CS Aksoy, E Kurpejovic, GG Toplan… - 2019 - aperta.ulakbim.gov.tr
Extrusion of drugs or drug-like compounds through bacterial efflux pumps is a serious health
issue that leads to loss in drug efficacy. Combinatorial therapies of low-efficacy drugs with …

Repurposing bioactive aporphine alkaloids as efflux pump inhibitors.

FG Avcİ, B Atas, CS Aksoy, E Kurpejovİc, GG Toplan… - 2019 - cabidigitallibrary.org
Extrusion of drugs or drug-like compounds through bacterial efflux pumps is a serious health
issue that leads to loss in drug efficacy. Combinatorial therapies of low-efficacy drugs with …

Repurposing bioactive aporphine alkaloids as efflux pump inhibitors.

FG Avci, B Atas, CS Aksoy, E Kurpejovic, C Gurer… - Fitoterapia, 2019 - europepmc.org
Extrusion of drugs or drug-like compounds through bacterial efflux pumps is a serious health
issue that leads to loss in drug efficacy. Combinatorial therapies of low-efficacy drugs with …

Repurposing bioactive aporphine alkaloids as efflux pump inhibitors

FG Avci, B Atas, CS Aksoy, E Kurpejovic… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Extrusion of drugs or drug-like compounds through bacterial efflux pumps is a serious health
issue that leads to loss in drug efficacy. Combinatorial therapies of low-efficacy drugs with …

Repurposing bioactive aporphine alkaloids as efflux pump inhibitors

F Avci, B Atas, C Aksoy, E Kurpejovic, G Toplan… - …, 2019 - avesis.istanbul.edu.tr
© 2019 Elsevier BV Extrusion of drugs or drug-like compounds through bacterial efflux
pumps is a serious health issue that leads to loss in drug efficacy. Combinatorial therapies of …
[PDF] academia.edu

[PDF][PDF] Repurposing bioactive aporphine alkaloids as efflux pump inhibitors

FG Avci, B Atas, CS Aksoy, E Kurpejovic, GG Toplan… - academia.edu
Extrusion of drugs or drug-like compounds through bacterial efflux pumps is a serious health
issue that leads to loss in drug efficacy. Combinatorial therapies of low-efficacy drugs with …

Repurposing bioactive aporphine alkaloids as efflux pump inhibitors

F Avci, B Atas, C Aksoy, E Kurpejovic… - …, 2019 - avesis.marmara.edu.tr
Extrusion of drugs or drug-like compounds through bacterial efflux pumps is a serious health
issue that leads to loss in drug efficacy. Combinatorial therapies of low-efficacy drugs with …
[PDF] academia.edu

[PDF][PDF] Repurposing bioactive aporphine alkaloids as efflux pump inhibitors

FG AVCI, B ATAS, CS AKSOY, E KURPEJOVIC… - academia.edu
Extrusion of drugs or drug-like compounds through bacterial efflux pumps is a serious health
issue that leads to loss in drug efficacy. Combinatorial therapies of low-efficacy drugs with …